182 related articles for article (PubMed ID: 9211191)
1. Clinical heterogeneity and molecular mechanisms in inborn muscle AMP deaminase deficiency.
Gross M
J Inherit Metab Dis; 1997 Jun; 20(2):186-92. PubMed ID: 9211191
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance and neuropathology of primary MADD in C34-T and G468-T mutations of the AMPD1 gene.
Fischer S; Drenckhahn C; Wolf C; Eschrich K; Kellermann S; Froster UG; Schober R
Clin Neuropathol; 2005; 24(2):77-85. PubMed ID: 15803807
[TBL] [Abstract][Full Text] [Related]
3. A G468-T AMPD1 mutant allele contributes to the high incidence of myoadenylate deaminase deficiency in the Caucasian population.
Gross M; Rötzer E; Kölle P; Mortier W; Reichmann H; Goebel HH; Lochmüller H; Pongratz D; Mahnke-Zizelman DK; Sabina RL
Neuromuscul Disord; 2002 Aug; 12(6):558-65. PubMed ID: 12117480
[TBL] [Abstract][Full Text] [Related]
4. Molecular biology of AMP deaminase deficiency.
Gross M
Pharm World Sci; 1994 Apr; 16(2):55-61. PubMed ID: 8032342
[TBL] [Abstract][Full Text] [Related]
5. [Myoadenylate deaminase deficiency in a child with myalgias induced by physical exercise].
Pantoja-Martínez J; Navarro Fernández-Balbuena C; Gormaz-Moreno M; Quintans-Castro B; Esparza-Sánchez MA; Bonet-Arzo J
Rev Neurol; 2004 Sep 1-15; 39(5):431-4. PubMed ID: 15378456
[TBL] [Abstract][Full Text] [Related]
6. First missense mutations (R388W and R425H) of AMPD1 accompanied with myopathy found in a Japanese patient.
Morisaki H; Higuchi I; Abe M; Osame M; Morisaki T
Hum Mutat; 2000 Dec; 16(6):467-72. PubMed ID: 11102975
[TBL] [Abstract][Full Text] [Related]
7. Myoadenylate deaminase deficiency. A common inherited defect with heterogeneous clinical presentation.
Sabina RL
Neurol Clin; 2000 Feb; 18(1):185-94. PubMed ID: 10658174
[TBL] [Abstract][Full Text] [Related]
8. Normal restriction pattern (Hind III) of the myoadenylate deaminase gene in enzyme deficient patients.
Gross M; Morisaki T; Pongratz D; Holmes EW; Zöllner N
Klin Wochenschr; 1990 Nov; 68(21):1084. PubMed ID: 2084323
[No Abstract] [Full Text] [Related]
9. Myoadenylate deaminase deficiency: a frequent cause of muscle pain A case detected by exercise testing.
Lim L; Palayer M; Bruneau A; Letournel F; Le Maréchal C; Simard G; Reynier P; Homedan C; Nadaj-Pakleza A
Ann Biol Clin (Paris); 2017 Aug; 75(4):445-449. PubMed ID: 28751290
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of AMP deaminase deficiency in skeletal muscle.
Morisaki T; Gross M; Morisaki H; Pongratz D; Zöllner N; Holmes EW
Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6457-61. PubMed ID: 1631143
[TBL] [Abstract][Full Text] [Related]
11. Effects of AMPD1 common mutation on the metabolic-chronotropic relationship: Insights from patients with myoadenylate deaminase deficiency.
Rannou F; Scotet V; Marcorelles P; Monnoyer R; Le Maréchal C
PLoS One; 2017; 12(11):e0187266. PubMed ID: 29095874
[TBL] [Abstract][Full Text] [Related]
12. Myoadenylate deaminase deficiency: clinico-pathological and molecular study of a series of 27 Spanish cases.
Teijeira S; San Millán B; Fernández JM; Rivas E; Viéitez I; Miranda S; González F; Navarro C
Clin Neuropathol; 2009; 28(2):136-42. PubMed ID: 19353846
[TBL] [Abstract][Full Text] [Related]
13. Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle.
Sabina RL; Swain JL; Olanow CW; Bradley WG; Fishbein WN; DiMauro S; Holmes EW
J Clin Invest; 1984 Mar; 73(3):720-30. PubMed ID: 6707201
[TBL] [Abstract][Full Text] [Related]
14. Association of genetically proven deficiencies of myophosphorylase and AMP deaminase: a second case of 'double trouble'.
Rubio JC; Martín MA; Bautista J; Campos Y; Segura D; Arenas J
Neuromuscul Disord; 1997 Sep; 7(6-7):387-9. PubMed ID: 9327403
[TBL] [Abstract][Full Text] [Related]
15. Alternative splicing: a mechanism for phenotypic rescue of a common inherited defect.
Morisaki H; Morisaki T; Newby LK; Holmes EW
J Clin Invest; 1993 May; 91(5):2275-80. PubMed ID: 8486786
[TBL] [Abstract][Full Text] [Related]
16. Familial myoadenylate deaminase deficiency and exertional myalgia.
Kelemen J; Rice DR; Bradley WG; Munsat TL; DiMauro S; Hogan EL
Neurology; 1982 Aug; 32(8):857-63. PubMed ID: 7201581
[TBL] [Abstract][Full Text] [Related]
17. Myoadenylate deaminase deficiency: absence of correlation with exercise intolerance in 452 muscle biopsies.
Mercelis R; Martin JJ; de Barsy T; Van den Berghe G
J Neurol; 1987 Aug; 234(6):385-9. PubMed ID: 3655841
[TBL] [Abstract][Full Text] [Related]
18. Myoadenylate deaminase deficiency with severe rhabdomyolysis.
Baumeister FA; Gross M; Wagner DR; Pongratz D; Eife R
Eur J Pediatr; 1993 Jun; 152(6):513-5. PubMed ID: 8335021
[TBL] [Abstract][Full Text] [Related]
19. Genetic characteristics of myoadenylate deaminase deficiency.
Verzijl HT; van Engelen BG; Luyten JA; Steenbergen GC; van den Heuvel LP; ter Laak HJ; Padberg GW; Wevers RA
Ann Neurol; 1998 Jul; 44(1):140-3. PubMed ID: 9667605
[TBL] [Abstract][Full Text] [Related]
20. AMP deaminase deficiency is associated with lower sprint cycling performance in healthy subjects.
Fischer H; Esbjörnsson M; Sabina RL; Strömberg A; Peyrard-Janvid M; Norman B
J Appl Physiol (1985); 2007 Jul; 103(1):315-22. PubMed ID: 17463303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
